Cubist Systematic Strategies »

Tourmaline Bio shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-06-30 $487k 38k 12.86
2023-12-31 $399k 15k 26.18

More positions owned by Cubist Systematic Strategies

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Microsoft Corporation (MSFT)
Super Micro Computer Call Option (SMCI)
General Motors Company (GM)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
Micron Technology Call Option (MU)
Arm Holdings Sponsored Ads Call Option (ARM)
Intel Corporation Call Option (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Snowflake Cl A (SNOW)
Tesla Motors Call Option (TSLA)

View all positions for Cubist Systematic Strategies

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
QVT Financial
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
State Street Corporation
Morgan Stanley

View all funds holding Tourmaline Bio